Intriguingly, recent epidemiological findings indicate that breast tumor sensitivity to exercise may differ as a function of clinical subtype with estrogen-receptor (ER) positive breast cancer being preferentially sensitive [4–6], although two independent cohort studies found triple negative tumors also to be responsive [7, 8]. This evidence concerns the gene ESR1 and breast carcinoma.